Recent News for CTLT - Catalent, Inc.

Date Title
Apr 7 Catalent (CTLT) Expands Deal With Moderna for COVID-19 Vaccine
Apr 6 Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated Vial Filling of Moderna’s COVID-19 Vaccine and Clinical Portfolio
Apr 6 Moderna to double its COVID-19 vaccine output at Catalent facility
Apr 6 Catalent To Boost Output Of Finished Vials For Moderna's COVID-19 Shot: WSJ
Apr 6 UPDATE 1-Catalent to nearly double U.S. production of Moderna's COVID-19 vaccine - WSJ
Apr 6 Contract drug maker Catalent to double production of Moderna COVID vaccine: WSJ
Mar 31 UPDATE 1-J&J says batch of COVID-19 vaccine ingredient fails to meet quality standards
Mar 29 Catalent (CTLT) Shines Bright in Madison Fund’s Q4 2020 Portfolio
Mar 28 Catalent: COVID-19 Opportunities Continue To Materialize
Mar 25 Time to Focus on Catalent (CTLT) for Strong Earnings Growth Potential
Mar 25 Here's Why I'm Avoiding AstraZeneca Stock
Mar 24 J&J COVID-19 Vaccine To Get Supply Boost As Manufacturing Partner Secures Key FDA Clearance
Mar 23 JNJ COVID-19 vaccine deliveries to rise as Catalent facility in Indiana gets FDA nod
Mar 23 UPDATE 1-Catalent says J&J COVID-19 vaccine manufacturing facility received FDA authorization
Mar 23 Catalent receives FDA approval to produce J&J vaccine - Bloomberg
Mar 23 Catalent Gets FDA OK to Produce More Doses of J&J Vaccine: Report
Mar 22 Cybin inks drug development agreement with Catalent
Mar 22 Cybin Signs Drug Development Agreement with Catalent for its Fast-Dissolve Formulation of Novel, Deuterated Tryptamine (CYB003)
Mar 18 Estimating The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)
Mar 18 Spacs vs short-sellers: the great money grab of 2021?
Mar 17 UPDATE 2-Catalent to ramp up J&J vaccine production at Italian plant
Mar 17 Catalent to ramp up J&J vaccine production at Italian plant
Mar 17 AstraZeneca and Catalent defend Covid vaccine manufacturing process
Mar 15 Catalent (CTLT) Sees Hammer Chart Pattern: Time to Buy?
Mar 3 Novavax taps Polish biotech firm Mabion for COVID-19 vaccine production
Back to the Main CTLT Page...